| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |